1 of 50

TUBERCULOSIS

DR KWAGHE BARKA VANDI

CONSULTANT ANATOMIC PATHOLOGIST

DEPARTMENT OF HISTOPATHOLOGY JUTH

2 of 50

OUTLINE

  • INTRODUCTION
  • AETIOLOGY
  • EPIDEMIOLOGY
  • PATHOGENESIS
  • SITES OF INFECTIONS
  • CLINICAL FEATURES
  • DIAGNOSIS
  • WORLD TUBERCULOSIS DAY

3 of 50

INTRODUCTION

  • TUBERCULOSIS IS AN ANCIENT SCOURGE

  • HAS PLAGUED HUMANKIND THROUGHOUT KNOWN HISTORY AND HUMAN PREHISTORY

  • IT IS A SERIOUS CHRONIC PULMONARY AND SYSTEMIC DISEASE CAUSED MOST OFTEN BY M. TUBERCULOSIS

4 of 50

INTRODUCTION

  • MYCOBACTERIUM TUBERCULOSIS MAY HAVE KILLED MORE PERSONS THAN ANY OTHER MICROBIAL PATHOGEN

5 of 50

AETIOLOGY

  • ON MARCH 24, 1882, DR. ROBERT KOCH ANNOUNCED THE DISCOVERY OF MYCOBACTERIUM TUBERCULOSIS, THE BACTERIA THAT CAUSE TUBERCULOSIS (TB)

  • THE GENUS MYCOBACTERIUM ARE SLENDER, AEROBIC RODS THAT GROW IN STRAIGHT OR BRANCHING CHAINS

6 of 50

AETIOLOGY

  • MYCOBACTERIA HAVE A UNIQUE WAXY CELL WALL COMPOSED OF UNUSUAL GLYCOLIPIDS AND LIPIDS INCLUDING MYCOLIC ACID

  • THESE MAKES THEM ACID-FAST, MEANING THEY RETAIN STAINS EVEN ON TREATMENT WITH A MIXTURE OF ACID AND ALCOHOL.

  • THEY ARE WEAKLY GRAM POSITIVE

7 of 50

EPIDEMIOLOGY

  • ACCORDING TO THE WHO, TUBERCULOSIS IS ESTIMATED TO AFFECT MORE THAN A BILLION INDIVIDUALS WORLDWIDE

  • THERE ARE 8 - 10 MILLION NEW CASES AND 1.6 MILLION DEATHS EACH YEAR

  • 13% OF THE PEOPLE WHO DEVELOPED TUBERCULOSIS IN 2011 WERE HIV-POSITIVE.

8 of 50

EPIDEMIOLOGY

  • TUBERCULOSIS IS THE SECOND-MOST COMMON CAUSE OF DEATH FROM INFECTIOUS DISEASE IN THE WORLD

  • IT IS MORE COMMON IN DEVELOPING COUNTRIES

  • ABOUT 80% OF THE POPULATION IN MANY ASIAN AND AFRICAN COUNTRIES TEST POSITIVE IN TUBERCULIN TESTS

  • 5–10% OF THE US POPULATION TEST POSITIVE

9 of 50

EPIDEMIOLOGY

  • IT FLOURISHES WHERE THERE IS POVERTY, CROWDING, AND CHRONIC DEBILITATING ILLNESSES

  • THE MAJOR SOURCE OF TRANSMISSION IS HUMANS WITH ACTIVE PULMONARY TUBERCULOSIS

  • HUMANS ARE THE ONLY RESERVOIR FOR M. TUBERCULOSIS

10 of 50

EPIDEMIOLOGY

  • PEOPLE WITH ACTIVE PULMONARY TUBERCULOSIS RELEASE MYCOBACTERIA PRESENT IN THEIR SPUTUM INTO THE ENVIROMENT

  • OROPHARYNGEAL AND INTESTINAL TUBERCULOSIS CAN BE CONTRACTED BY DRINKING MILK CONTAMINATED WITH MYCOBACTERIUM BOVIS

11 of 50

PATHOGENESIS

  • M. TUBERCULOSIS ENTERS MACROPHAGES BY PHAGOCYTOSIS MEDIATED BY SEVERAL RECEPTORS EXPRESSED ON THE PHAGOCYTE

  • INCLUDING MANNOSE BINDING LECTIN AND CR3

  • REPLICATION TAKES PLACE IN MACROPHAGES BY INHIBITING MATURATION OF PHAGOSOME AND FORMATION OF PHAGOLYSOSOME

12 of 50

PATHOGENESIS

  • THIS OCCURS DURING THE FIRST 3 WEEKS OF INFECTION IN PRIMARY TUBERCULOSIS (IN NONSENSITIZED INDIVIDUALS)

13 of 50

PATHOGENESIS

14 of 50

PATHOGENESIS

  • MYCOBACTERIA PROLIFERATE IN THE PULMONARY ALVEOLAR MACROPHAGES AND AIR SPACES, RESULTING IN BACTEREMIA AND SEEDING OF MULTIPLE SITES

  • MULTIPLE PATHOGEN ASSOCIATED MOLECULAR PATTERNS OF M. TUBERCULOSIS, INCLUDING LIPOPROTEINS AND GLYCOLIPIDS, ARE RECOGNIZED BY THE INNATE IMMUNE RECEPTORS E.G. TOLL-LIKE RECEPTORS SUCH AS TLR2

15 of 50

PATHOGENESIS

  • THIS INITIATES AND ENHANCES THE INNATE AND ADAPTIVE IMMUNE RESPONSES TO M. TUBERCULOSIS AT 3 WEEKS POST INFECTION

  • STIMULATION OF TLR2 BY MYCOBACTERIAL LIGANDS PROMOTES PRODUCTION OF IL-12 BY ANTIGEN PRESENTING CELLS (APC, DENTRITIC CELLS AND MACROPHAGES)

  • NAIVE CD4+ T-CELLS RECOGNIZE PEPTIDES DISPLAYED BY APC AND THE IL-12 SECRETED BY THEM

16 of 50

PATHOGENESIS

  • THIS INDUCES THE DIFFERENTIATION OF NAIVE CD4+ T-CELLS INTO TH1 SUBSET

  • THESE TH1 CELLS SECRETE IFN-Ƴ WHICH ACTIVATES MACROPHAGES

  • THESE CLASSICALLY ACTIVATED MACROPHAGES ARE ALTERED IN SEVERAL WAYS:-

17 of 50

PATHOGENESIS

  • 1. THEIR ABILITY TO PHAGOCYTOSE AND KILL MICROORGANISMS IS MARKEDLY AUGMENTED BY MATURATION OF PHAGOLYSOSOME IN INFECTED MACROPHAGES

  • 2. STIMULATION OF INDUCIBLE NITRIC OXIDE SYNTHASE

18 of 50

PATHOGENESIS

  • 3. EXPRESS MORE CLASS II MHC MOLECULES ON THEIR SURFACES

  • 4. THEY SECRETE TNF, IL-1 AND CHEMOKINES WHICH PROMOTES INFLAMMATION

19 of 50

PATHOGENESIS

  • 5. STIMULATES THE FORMATION OF GRANULOMA AND CASEOUS NECROSIS

  • 6. MACROPHAGES ACTIVATED BY INF-Ƴ ARE TRANSFORMED INTO EPITHELIOID CELLS WHICH AGGREGATE TO FORM GRANULOMAS

  • 7. SOME EPITHELIOID CELLS FUSE TO FORM GIANT CELLS (LANGHAN TYPE)

20 of 50

PATHOGENESIS

21 of 50

SITES OF INFECTION

  • LUNGS/PULMONARY TUBERCULOSIS

  • LYMPH NODES/LYMPHADENITIS

  • GASTROINTESTINAL

  • ADRENAL GLANDS/RENAL

  • CNS/ TB MENINGITIS

22 of 50

SITES OF INFECTION

  • OSTEO-ARTICULAR…E.G. OTEOMYELITIS/POTT DISEASE

  • CUTANEOUS/SKIN

  • CARDIAC

  • GENITO-URINARY

23 of 50

CLINICAL FEATURES

  • SYSTEMIC SYMPTOMS ARE RELATED TO CYTOKINES RELEASED BY ACTIVATED MACROPHAGES (E.G., TNF AND IL-1)

  • INCLUDE; MALAISE, ANOREXIA, CACHEXIA, AND FEVER.

  • THE FEVER IS LOW GRADE AND REMITTENT (APPEARING EACH LATE AFTERNOON AND THEN SUBSIDING), AND NIGHT SWEATS OCCUR.

24 of 50

PULMONARY TUBERCULOSIS

THERE ARE TWO PATHOPHYSOLOGICAL TYPES OF CLINICAL TUBERCULOSIS:-

  1. PRIMARY (IN NON-SENSITIZED INDIVIDUALS)

  • SECONDARY (IN SENSITIZED INDIVIDUALS)

25 of 50

PRIMARY PULMONARY TUBERCULOSIS

  • OCCURS IN 5% OF NEWLY INFECTED PEOPLE

  • THE SOURCE OF INFECTION IS EXOGENOUS

  • IN MOST PEOPLE THIS IS CONTAINED, BUT IN SOME IT IS PROGRESSIVE

  • IT RESEMBLES AN ACUTE BACTERIAL PNEUMONIA WITH LOBAR CONSOLIDATION, HILAR ADENOPATHY AND PLEURAL EFFUSSION

26 of 50

MILIARY TUBERCULOSIS

MILIARY PULMONARY DISEASE

  • ORGANISMS DRAINING THROUGH LYMPHATICS MAY ENTER THE VENOUS BLOOD AND CIRCULATE BACK TO THE LUNG

  • GIVING MICROSCOPIC OR SMALL, VISIBLE LESIONS (2-MM), FOCI OF YELLOW-WHITE CONSOLIDATIONSCATTERED THROUGH THE LUNG PARENCHYMA

27 of 50

MILIARY TUBERCULOSIS

  • LATER CONSOLIDATION OF LARGE REGIONS OR EVEN WHOLE LOBES OF THE LUNG WILL BE INVOVLED

  • WITH PROGRESSIVE PULMONARY TUBERCULOSIS, THE PLEURAL CAVITY IS INVARIABLY INVOLVED, AND SEROUS PLEURAL EFFUSIONS, TUBERCULOUS EMPYEMA, OR OBLITERATIVE FIBROUS PLEURITIS MAY DEVELOP

28 of 50

MILIARY TUBERCULOSIS

SYSTEMIC MILIARY TUBERCULOSIS

  • OCCURS WHEN BACTERIA DISSEMINATE THROUGH THE SYSTEMIC ARTERIAL SYSTEM

  • MILIARY TUBERCULOSIS IS MOST PROMINENT IN THE LIVER, BONE MARROW, SPLEEN, ADRENALS, MENINGES, KIDNEYS, FALLOPIAN TUBES, AND EPIDIDYMIS, BUT COULD INVOLVE ANY ORGAN

29 of 50

MILIARY TUBERCULOSIS

30 of 50

SECONDARY PULMONARY TUBERCULOSIS

  • THIS MAY FOLLOW SHORTLY AFTER PRIMARY TUBERCULOSIS

  • MOST OFTEN YEARS AFTER INITIAL INFECTION BY REACTIVATION OF LATENT INFECTION OR BY EXOGENOUS RE-INFECTION

  • CHARACTERIZED MOSTLY BY CAVITATIONS IN THE APEX OF UPPER LOBES AND EROSION OF CAVITIES INTO AIRWAYS (ASSMAN FOCUS)

31 of 50

SECONDARY PULMONARY TUBERCULOSIS

  • WITH PROGRESSIVE PULMONARY INVOLVEMENT, THERE IS INCREASING AMOUNTS OF SPUTUM, AT FIRST MUCOID AND LATER PURULENT

  • SOME DEGREE OF HEMOPTYSIS IS PRESENT IN ABOUT HALF OF ALL CASES OF PULMONARY TUBERCULOSIS

32 of 50

LUNGS/CHEST X-RAY

33 of 50

LUNGS/GROSS

GHON COMPLEX

GHON COMPLEX

34 of 50

LUNGS/GROSS

CAVITATORY TUBERCULOSIS

MILIARY TUBERCULOSIS

35 of 50

GRANULOMA WITH CENTRAL NECROSIS

36 of 50

GRANULOMA

37 of 50

GRANULOMA

38 of 50

EXTRAPULMONARY TUBERCULOSIS

  • CNS TB MAY PRESENT WITH MENINGITIS OR INTRACRANIAL TUBERCULOMAS

  • ABDOMINAL TB INCLUDES TB PERITONITIS AND TB OF THE GI TRACT

39 of 50

EXTRAPULMONARY TUBERCULOSIS

  • DISSEMINATED TB; MOST COMMONLY INVOLVED ORGANS (IN ORDER) ARE LUNGS, LIVER, SPLEEN, KIDNEYS, AND BONE MARROW

  • POTT DISEASE IS A PRESENTATION OF EXTRAPULMONARY TUBERCULOSIS WHEREBY DISEASE IS SEEN IN THE SPINAL VERTEBRAE

40 of 50

GIBBUS IN POTT DISEAESE

41 of 50

POTT DISEASE

42 of 50

43 of 50

DIAGNOSIS

  • TUBERCULOSIS IS DIAGNOSED BY FINDING MYCOBACTERIUM TUBERCULOSIS BACTERIA IN A CLINICAL SPECIMEN TAKEN FROM THE PATIENT

  • ACID-FAST BACILLI (AFB) SMEAR

ZIEHL NEELSEN STAIN (ACID-FAST STAIN)

  • BACTERIOLOGICAL CULTURE TESTS

LOWENSTEIN-JENSEN MEDIA

  • BACTEC RADIOMETRIC CULTURE SYSTEM FOR BACTERIA (9-16DAYS)

44 of 50

DIAGNOSIS

  • MYCOBACTERIAL CULTURE, WHICH HAS THE HIGHEST SENSITIVITY FOR DIAGNOSING AND CONFIRMING ACTIVE TB, REQUIRES 2 TO 6 WEEKS FOR INTERPRETATION

  • WHILE OTHER INVESTIGATIONS MAY STRONGLY SUGGEST TUBERCULOSIS AS THE DIAGNOSIS, THEY CANNOT CONFIRM IT.

45 of 50

DIAGNOSIS

  • A COMPLETE MEDICAL EVALUATION FOR TUBERCULOSIS (TB) MUST INCLUDE A MEDICAL HISTORY, A PHYSICAL EXAMINATION, A CHEST X-RAY AND MICROBIOLOGICAL EXAMINATION OF SPUTUM OR SOME OTHER APPROPRIATE SAMPLES

  • IT MAY ALSO INCLUDE A TUBERCULIN SKIN TEST, OTHER SCANS AND X-RAYS,

  • SURGICAL BIOPSY FOR HISTOLOGY

46 of 50

HIV /AIDS AND TB

  • ALL STAGES OF HIV INFECTION ARE ASSOCIATED WITH AN INCREASED RISK OF TUBERCULOSIS.

  • HIV-POSITIVE PEOPLE HAVE AN INCREASED FREQUENCY OF FALSE-NEGATIVE SPUTUM SMEARS AND TUBERCULIN TESTS (THE LATTER SOMETIMES REFERRED TO AS “ANERGY”)

  • THERE IS ABSENCE OF CHARACTERISTIC GRANULOMAS IN TISSUES, PARTICULARLY IN THE LATE STAGES OF HIV.

47 of 50

WORLD TB DAY

  • 24TH OF MARCH EACH YEAR.

  • IT COMMEMORATES THE DAY IN 1882 WHEN DR ROBERT KOCH ASTOUNDED THE SCIENTIFIC COMMUNITY BY ANNOUNCING THAT HE HAD DISCOVERED THE CAUSE OF TUBERCULOSIS

  • THE TB BACILLUS

48 of 50

WORLD TB DAY

THE EVENT WAS INTENDED TO EDUCATE THE PUBLIC ABOUT:-

  • 1. THE DEVASTATING HEALTH AND ECONOMIC CONSEQUENCES OF TB.

  • 2. ITS EFFECTS ON DEVELOPING COUNTRIES, AND ITS CONTINUED TRAGIC IMPACT ON GLOBAL HEALTH.

49 of 50

WORLD TB DAY

  • UNTIL TB IS CONTROLLED, THE WORLD TB DAY WON’T BE A CELEBRATION.

  • BUT A VALUABLE OPPORTUNITY TO EDUCATE THE PUBLIC ABOUT THE DEVASTATION CAUSED BY TB AND HOW SPREAD AND HOW IT CAN BE STOPPED.

50 of 50

THANK YOU